Impaired autophagy and delayed autophagic clearance of transforming growth factor β-induced protein (TGFBI) in granular corneal dystrophy type 2

Autophagy

Volumn 8, Issue 12, 2012, Pages 1782-1797

  Choi, Seung Il ^a   Kim, Bong Yoon ^a   Dadakhujaev, Shorafidinkhuja ^a   Oh, Jun Young ^a   Kim, Tae Im ^a   Kim, Joo Young ^a   Kim, Eung Kweon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Defective autophagy; LC3 MAP1LC3B; Rapamycin; SQSTM1 p62; TGFBI; Ubiquitination

Indexed keywords

ADENOVIRUS VECTOR; BAFILOMYCIN A1; CASPASE 3; GREEN FLUORESCENT PROTEIN; MUTANT PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA INDUCED PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; AUTOSOMAL DOMINANT DISORDER; CELL VIABILITY; CONTROLLED STUDY; CORNEA; CORNEA DYSTROPHY; DEGENERATIVE DISEASE; DISEASE CLASSIFICATION; FIBROBLAST; GRANULAR CORNEAL DYSTROPHY TYPE 2; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LYSOSOME; PATHOGENESIS; PROTEIN LOCALIZATION; PROTEIN SECRETION; UBIQUITINATION;

EID: 84870948406     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.22067     Document Type: Article

References (62)

1. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 2005; 6:79-87; PMID:15688069; http://dx.doi.org/10.1038/nrm1552
2. Finkbeiner S, Cuervo AM, Morimoto RI, Muchowski PJ. Disease-modifying pathways in neurodegeneration. J Neurosci 2006; 26:10349-57; PMID:17035516; http://dx.doi.org/10.1523/JNEUROSCI.3829-06.2006
3. Ward WF. Protein degradation in the aging organism. Prog Mol Subcell Biol 2002; 29:35-42; PMID:11908071; http://dx.doi.org/10.1007/978-3-642-56373-7-3
4. Martinez-Vicente M, Sovak G, Cuervo AM. Protein degradation and aging. Exp Gerontol 2005; 40:622-33; PMID:16125351; http://dx.doi.org/10.1016/j.exger. 2005.07.005
5. Todde V, Veenhuis M, van der Klei IJ. Autophagy: principles and significance in health and disease. Biochim Biophys Acta 2009; 1792:3-13; PMID:19022377; http://dx.doi.org/10.1016/j.bbadis.2008.10.016
6. Pattingre S, Espert L, Biard-Piechaczyk M, Codogno P. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 2008; 90:313-23; PMID:17928127; http://dx.doi.org/10.1016/j.biochi.2007.08.014
7. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451:1069-75; PMID:18305538; http://dx.doi.org/10.1038/nature06639
8. Munier FL, Korvatska E, Djemaï A, Le Paslier D, Zografos L, Pescia G, et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 1997; 15:247-51; PMID:9054935; http://dx.doi.org/10.1038/ng0397-247
9. Skonier J, Neubauer M, Madisen L, Bennett K, Plowman GD, Purchio AF. cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol 1992; 11:511-22; PMID:1388724; http://dx.doi.org/10.1089/dna.1992. 11.511
10. LeBaron RG, Bezverkov KI, Zimber MP, Pavelec R, Skonier J, Purchio AF. Beta IG-H3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J Invest Dermatol 1995; 104:844-9; PMID:7738366; http://dx.doi.org/10.1111/1523-1747.ep12607024
11. Billings PC, Herrick DJ, Kucich U, Engelsberg BN, Abrams WR, Macarak EJ, et al. Extracellular matrix and nuclear localization of beta ig-h3 in human bladder smooth muscle and fibroblast cells. J Cell Biochem 2000; 79:261-73; PMID:10967553; http://dx.doi.org/10.1002/1097-4644(20001101)79:2〈261:: AIDJCB90〉3.0.CO;2-#
12. Kim JE, Jeong HW, Nam JO, Lee BH, Choi JY, Park RW, et al. Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. J Biol Chem 2002; 277:46159-65; PMID:12270930; http://dx.doi.org/10. 1074/jbc.M207055200
13. Klintworth GK. Advances in the molecular genetics of corneal dystrophies. Am J Ophthalmol 1999; 128:747-54; PMID:10612512; http://dx.doi.org/10.1016/ S0002-9394(99)00358-X
14. Korvatska E, Henry H, Mashima Y, Yamada M, Bachmann C, Munier FL, et al. Amyloid and non-amyloid forms of 5q31-linked corneal dystrophy resulting from kerato-epithelin mutations at Arg-124 are associated with abnormal turnover of the protein. J Biol Chem 2000; 275:11465-9; PMID:10753964; http://dx.doi.org/10. 1074/jbc.275.15.11465
15. Okada M, Yamamoto S, Inoue Y, Watanabe H, Maeda N, Shimomura Y, et al. Severe corneal dystrophy phenotype caused by homozygous R124H keratoepithelin mutations. Invest Ophthalmol Vis Sci 1998; 39:1947-53; PMID:9727418
16. Cintron C, Schneider H, Kublin C. Corneal scar formation. Exp Eye Res 1973; 17:251-9; PMID:4271803; http://dx.doi.org/10.1016/0014-4835(73)90176-0
17. Cintron C, Kublin CL. Regeneration of corneal tissue. Dev Biol 1977; 61:346-57; PMID:590631; http://dx.doi.org/10.1016/0012-1606(77)90304-9
18. Jester JV, Moller-Pedersen T, Huang JY, Sax CM, Kays WT, Cavangh HD, et al. The cellular basis of corneal transparency: evidence for 'corneal crystallins'. J Cell Sci 1999; 112:613-22; PMID:9973596
19. Qazi Y, Wong G, Monson B, Stringham J, Ambati BK. Corneal transparency: genesis, maintenance and dysfunction. Brain Res Bull 2010; 81:198-210; PMID:19481138; http://dx.doi.org/10.1016/j.brain-resbull.2009.05.019
20. Akhtar S, Meek KM, Ridgway AE, Bonshek RE, Bron AJ. Deposits and proteoglycan changes in primary and recurrent granular dystrophy of the cornea. Arch Ophthalmol 1999; 117:310-21; PMID:10088808
21. Kim BY, Olzmann JA, Choi SI, Ahn SY, Kim TI, Cho HS, et al. Corneal dystrophy-associated R124H mutation disrupts TGFBI interaction with Periostin and causes mislocalization to the lysosome. J Biol Chem 2009; 284:19580-91; PMID:19478074; http://dx.doi.org/10.1074/jbc.M109.013607
22. Choi SI, Kim TI, Kim KS, Kim BY, Ahn SY, Cho HJ, et al. Decreased catalase expression and increased susceptibility to oxidative stress in primary cultured corneal fibroblasts from patients with granular corneal dystrophy type II. Am J Pathol 2009; 175:248-61; PMID:19497990; http://dx.doi.org/10.2353/ ajpath.2009.081001
23. Scherz-Shouval R, Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol 2007; 17:422-7; PMID:17804237; http://dx.doi.org/10. 1016/j.tcb.2007.07.009
24. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 2007; 26:1749-60; PMID:17347651; http://dx.doi.org/10. 1038/sj.emboj.7601623
25. Yu L, Wan F, Dutta S, Welsh S, Liu Z, Freundt E, et al. Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci U S A 2006; 103:4952-7; PMID:16547133; http://dx.doi.org/10.1073/pnas.0511288103
26. Kim TI, Kim H, Lee DJ, Choi SI, Kang SW, Kim EK. Altered mitochondrial function in type 2 granular corneal dystrophy. Am J Pathol 2011; 179:684-92; PMID:21699880; http://dx.doi.org/10.1016/j.ajpath.2011.04.005
27. Kim I, Rodriguez-Enriquez S, Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 2007; 462:245-53; PMID:17475204; http://dx.doi.org/10.1016/j.abb.2007.03.034
28. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2001; 1:515-25; PMID:11703942; http://dx.doi.org/10. 1016/S1534-5807(01)00055-7
29. Karbowski M, Lee YJ, Gaume B, Jeong SY, Frank S, Nechushtan A, et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol 2002; 159:931-8; PMID:12499352; http://dx.doi.org/10.1083/jcb.200209124
30. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19:5720-8; PMID:11060023; http://dx.doi.org/10.1093/emboj/19.21.5720
31. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441:885-9; PMID:16625204; http://dx.doi.org/10. 1038/nature04724
32. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006; 441:880-4; PMID:16625205; http://dx.doi.org/10.1038/nature04723
33. Bjørkøy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005; 171:603-14; PMID:16286508; http://dx.doi.org/10.1083/jcb.200507002
34. Kihara A, Kabeya Y, Ohsumi Y, Yoshimori T. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep 2001; 2:330-5; PMID:11306555; http://dx.doi.org/10.1093/emboreports/kve061
35. Mizushima N, Yoshimori T. How to interpret LC3 immunoblotting. Autophagy 2007; 3:542-5; PMID:17611390
36. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003; 112:1809-20; PMID:14638851
37. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003; 100:15077-82; PMID:14657337; http://dx.doi.org/10.1073/pnas.2436255100
38. Xue L, Fletcher GC, Tolkovsky AM. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci 1999; 14:180-98; PMID:10576889; http://dx.doi.org/10.1006/ mcne.1999.0780
39. Daido S, Kanzawa T, Yamamoto A, Takeuchi H, Kondo Y, Kondo S. Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 2004; 64:4286-93; PMID:15205343; http://dx.doi.org/10.1158/0008-5472.CAN-03-3084
40. Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL, et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 2007; 3:331-8; PMID:17486044; http://dx.doi.org/ 10.1038/nchembio883
41. Sarkar S, Davies JE, Huang ZB, Tunnacliffe A, Rubinsztein DC. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 2007; 282:5641-52; PMID:17182613; http://dx.doi.org/10.1074/jbc.M609532200
42. Blázquez M, Shennan KI. Basic mechanisms of secretion: sorting into the regulated secretory pathway. Biochem Cell Biol 2000; 78:181-91; PMID:10949073; http://dx.doi.org/10.1139/o00-010
43. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010; 73:1907-20; PMID:20601276; http://dx.doi.org/10.1016/j.jprot.2010.06.006
44. Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A 2006; 103:11172-7; PMID:16837572; http://dx.doi.org/10.1073/pnas.0603838103
45. Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, et al. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 2010; 30:6838-51; PMID:20484626; http://dx.doi.org/10.1523/JNEUROSCI.5699-09. 2010
46. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, et al. Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 2004; 101:9683-8; PMID:15210972; http://dx.doi.org/10.1073/pnas.0308413101
47. Kissová I, Deffieu M, Manon S, Camougrand N. Uth1p is involved in the autophagic degradation of mitochondria. J Biol Chem 2004; 279:39068-74; PMID:15247238; http://dx.doi.org/10.1074/jbc.M406960200
48. Rodriguez-Enriquez S, Kim I, Currin RT, Lemasters JJ. Tracker dyes to probe mitochondrial autophagy (mitophagy) in rat hepatocytes. Autophagy 2006; 2:39-46; PMID:16874071
49. Takeshige K, Baba M, Tsuboi S, Noda T, Ohsumi Y. Autophagy in yeast demonstrated with proteinasedeficient mutants and conditions for its induction. J Cell Biol 1992; 119:301-11; PMID:1400575; http://dx.doi.org/10.1083/jcb.119.2. 301
50. Settembre C, Fraldi A, Jahreiss L, Spampanato C, Venturi C, Medina D, et al. A block of autophagy in lysosomal storage disorders. Hum Mol Genet 2008; 17:119-29; PMID:17913701; http://dx.doi.org/10.1093/hmg/ddm289
51. Boya P, González-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 2005; 25:1025-40; PMID:15657430; http://dx.doi.org/10.1128/MCB.25.3.1025- 1040.2005
52. Settembre C, Annunziata I, Spampanato C, Zarcone D, Cobellis G, Nusco E, et al. Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency. Proc Natl Acad Sci U S A 2007; 104:4506-11; PMID:17360554; http://dx.doi.org/10.1073/pnas.0700382104
53. Ravikumar B, Berger Z, Vacher C, O'Kane CJ, Rubinsztein DC. Rapamycin pre-treatment protects against apoptosis. Hum Mol Genet 2006; 15:1209-16; PMID:16497721; http://dx.doi.org/10.1093/hmg/ddl036
54. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Codogno P. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 2000; 275:992-8; PMID:10625637; http://dx.doi.org/10.1074/jbc.275.2.992
55. Francesconi CM, Hutcheon AE, Chung EH, Dalbone AC, Joyce NC, Zieske JD. Expression patterns of retinoblastoma and E2F family proteins during corneal development. Invest Ophthalmol Vis Sci 2000; 41:1054-62; PMID:10752941
56. Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006; 443:780-6; PMID:17051204; http://dx.doi.org/10.1038/nature05291
57. Ravikumar B, Duden R, Rubinsztein DC. Aggregateprone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 2002; 11:1107-17; PMID:11978769; http://dx.doi.org/10.1093/hmg/11.9.1107
58. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004; 36:585-95; PMID:15146184; http://dx.doi.org/10.1038/ng1362
59. Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 2006; 15:433-42; PMID:16368705; http://dx.doi.org/10.1093/hmg/ddi458
60. Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006; 443:780-6; PMID:17051204; http://dx.doi.org/10.1038/nature05291
61. Wen GY, Hong M, Li BY, Liao WP, Cheng SK, Hu BR, et al. Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway. Int J Oncol 2011; 39:1001-9; PMID:21701776
62. Ng S, Wu YT, Chen B, Zhou J, Shen HM. Impaired autophagy due to constitutive mTOR activation sensitizes TSC2-null cells to cell death under stress. Autophagy 2011; 7:1173-86; PMID:21808151; http://dx.doi.org/10.4161/ auto.7.10.16681